Fornix BioSciences, Solvay, Value8: Benelux Equity Preview

The following companies may have unusual price changes in Benelux markets. Stock symbols are in parentheses, and prices are from the previous close.

The AEX-Index in Amsterdam advanced 4.11, or 1.2 percent, to 362.41. Belgium’s Bel20 Index climbed 46.70, or 1.8 percent, to 2,626.40. Luxembourg’s LuxX Index rose 0.5 percent to 1,491.63.

Dutch stocks:

Fornix BioSciences NV (FORBI NA): Value8 NV (VALUE NA) said it raised its holding in the Dutch maker of medical aids to 24.91 percent from 16.3 percent on Sept. 23. Fornix advanced 1.4 percent to 2.25 euros and Value8 lost 1.5 percent to 24.60 euros.

Belgian stocks:

Solvay SA (SOLB BB): The chemicals and plastics maker that sold its drug division to Abbott Laboratories last year said it will repurchase as many as 1.65 million shares in 2011, potentially almost doubling last year’s stock buybacks. Solvay increased 0.5 percent to 78 euros.

To contact the reporters on this story: John Martens in Brussels at jmartens1@bloomberg.net; Martijn van der Starre in Amsterdam at vanderstarre@bloomberg.net

To contact the editor responsible for this story: Angela Cullen at acullen8@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.